RACHEL ZOLLMAN: Open Payments
NPI 1134271794 · ROCKFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 63 payments from 17 companies in 2025. Trend: 2023 $1,692 · 2024 $1,555 · 2025 $1,587
Food & beverage: $1,488Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $185 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| Janssen Biotech, Inc. | 4 | $169 |
| Regeneron Healthcare Solutions, Inc. | 8 | $141 |
| GENZYME CORPORATION | 5 | $132 |
| UCB, Inc. | 4 | $120 |
| Journey Medical Corporation | 1 | $88 |
| LEO Pharma Inc. | 4 | $84 |
| ABBVIE INC. | 3 | $81 |
| PFIZER INC. | 4 | $80 |
Products named: OPZELURA, DUPIXENT, COSENTYX, TREMFYA, Bimzelx, RINVOQ, LIBTAYO, Zoryve.
Industry payments across MI — which companies pay providers there.
